FindTrial
Sign In

Treatment method and blood transfusion strategy for neonatal RhD antigen masking caused by high titer anti-D antibody

Treatment method and blood transfusion strategy for neonatal RhD antigen masking caused by high titer anti-D antibody

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097764
Enrollment
Unknown
Registered
2025-02-25
Start date
2021-08-18
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal RhD antigen masking

Interventions

neonatal RhD antigen masking caused by high titer anti-Dantibody:NA

Sponsors

Xiamen Maternal and Child Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1.one case of neonatal RhD antigen masking caused by high titer anti-Dantibody;

Exclusion criteria

Exclusion criteria: 1.none;

Design outcomes

Primary

MeasureTime frame
neonatal RhD antigen masking caused by high titer anti-Dantibody;bilirubin;—

Countries

China

Contacts

Public ContactLuo Yuanyuan

Xiamen Maternal and Child Care Hospital

157826163@qq.com+86 592 2663634

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026